Divalproex Sodium Tablet, Delayed Release
Product Images NDC 0615-8586

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 0615-8586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Divalproex Sodium Dr Tabs 8586 8587 8588 1)

Chemical structure of divalproex sodium, showing its molecular configuration with sodium ion and branched alkyl groups.*

FDA Label Image

Figure1 (Divalproex Sodium Dr Tabs 8586 8587 8588 2)

A bar graph comparing percentage values between placebo (PBO) and divalproex sodium (DVPX) groups across two studies. The y-axis represents percentage from 0% to 70%. Study 1 shows about 26% for PBO and 60% for DVPX, while Study 2 shows about 29% for PBO and 58% for DVPX, indicating higher percentages in the DVPX groups in both studies.*

FDA Label Image

Figure2 (Divalproex Sodium Dr Tabs 8586 8587 8588 3)

A line graph depicting the percentage reduction in CPS rate on the vertical axis and the percentage of patients on the horizontal axis. The graph compares treatment with divalproex sodium versus placebo, showing improvement and worsening trends.*

FDA Label Image

Figure3 (Divalproex Sodium Dr Tabs 8586 8587 8588 4)

A line graph showing the percentage reduction in CPS rate versus the percentage of patients for high and low doses of divalproex sodium. The graph includes axes labeled with percentage of patients and reduction in CPS rate, illustrating changes in patients' conditions with high and low doses.*

FDA Label Image

Figure4 (Divalproex Sodium Dr Tabs 8586 8587 8588 5)

Bar graph comparing two studies showing values for placebo versus divalproex sodium in each study, illustrating a decrease in values for divalproex sodium compared to placebo in both studies. Axes display numerical scale and group labels, but specific data points and units are not visible.*

FDA Label Image

Principal Display Panel (Divalproex Sodium Dr Tabs 8586 8587 8588 6)

Label for divalproex sodium delayed-release tablets, USP 125 mg, provided in a quantity of 30 tablets. Manufactured by Orbion Pharmaceuticals for Bionpharma and packaged by Vangard Labs, Glasgow, KY. Includes barcodes, lot number, expiration date placeholders, and institutional use instructions. The label emphasizes storage conditions and dosage form as enteric-coated delayed-release tablets.*

FDA Label Image

Principal Display Panel (Divalproex Sodium Dr Tabs 8586 8587 8588 7)

This image shows a label for Divalproex Sodium Delayed-Release Tablets, USP 250 mg, in a quantity of 30 tablets. The label includes multiple barcodes, lot number 8587, and indicates packaging by Vangard Labs, Glasgow, KY. The label mentions the product is for institutional use only and contains storage instructions. Manufacturer is Orbion Pharmaceuticals for Bionpharma.*

FDA Label Image

Principal Display Panel (Divalproex Sodium Dr Tabs 8586 8587 8588 8)

Label for divalproex sodium delayed-release tablets USP 500 mg. The label includes the product name, strength, dosage form, quantity of 30 tablets, lot number 8588, and barcode. Labeler information is NCS HealthCare of KY, LLC dba Vangard Labs, with packaging by Vangard in Glasgow, KY. It notes storage instructions and indicates the product is for institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.